Production deployment
Production deployment on Beyond Market Intelligence: a running collection of 2 stories we have gathered and hand-picked because they are worth your time. Every post here touches on production deployment in some way — the news, the analysis, the deep dives, and the occasional surprise find. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work with data. New stories are added to this page as we find them, so check back if you want to keep up with what is happening around production deployment, or subscribe to the RSS feed to get them as soon as they are published. Browse the collection below, or head back to the homepage to see everything Beyond Market Intelligence is covering right now.

The agent evaluation gap: Enterprise AI organizations have a reality-alignment problem, not a coverage problem — and most are shipping to production anyway
Enterprise AI organizations face a critical reality-alignment problem: an “evaluation gap” where increasing agent autonomy outpaces trust in the evaluations meant to govern it. A recent VentureBeat Pulse Research survey of 157 enterprises reveals that half have already deployed an agent that passed internal evaluations but subsequently failed a customer. Only 5% fully trust automated evaluation, citing a key weakness – evaluations often don't reflect real-world outcomes. Despite this, two-thirds are moving toward fully automated deployments, highlighting a pressing need for more reliable assurance.

Amazon AGI director says AI agent reliability, not capability, is blocking enterprise deployment at VB Transform 2026
Amazon’s Bryan Silverthorn, Director of AGI Autonomy, recently pinpointed a critical obstacle hindering enterprise AI agent deployment: reliability, not inherent capability. Addressing attendees at VB Transform 2026, Silverthorn highlighted a concerning trend – 85% of enterprises pilot AI agents, yet only 5% reach production. His framework, emphasizing consistency, robustness, predictability, and safety, underscores the need for rigorous measurement, echoing findings that many agents fail after initial evaluations.